Page 66 - 南京医科大学自然版
P. 66

第46卷第8期
               ·1172 ·                           南 京    医 科 大 学 学         报                        2026年8月


              负责论文排版及初稿的修改。缪林和邓雪婷指导论文核心                              tural basis for the intracellular regulation of ferritin degra⁃
              方向,并对综述最终稿进行审校与定稿。                                     dation[J]. Nat Commun,2024,15(1):3802
                  Author’s Contributions:                       [10]SUI X,WANG J,ZHAO Z,et al. Phenolic compounds in⁃
                  ZHANG Jingyu was responsible for the topic selection,  duce ferroptosis⁃like death by promoting hydroxyl radical
              framework design and drafting of the initial manuscript of the re⁃  generation in the fenton reaction[J]. Commun Biol,2024,
              view. WENG Zirui was responsible for the manuscript format⁃  7(1):199
              ting and revision of the initial draft. MIAO Lin and DENG Xuet⁃  [11]ZENG K,LI W,WANG Y,et al. Inhibition of CDK1 over⁃
              ing provided guidance on the core direction of the review and  comes oxaliplatin resistance by regulating ACSL4⁃mediat⁃
              were responsible for reviewing and finalizing the final version of  ed ferroptosis in colorectal cancer[J]. Adv Sci(Weinh),
              the review.                                            2023,10(25):e2301088
                                                                [12]WEN F,LING H,RAN R,et al. LPCAT3 regulates the
             [参考文献]
                                                                     proliferation and metastasis of serous ovarian cancer by
             [1] BRAY F,LAVERSANNE M,SUNG H,et al. Global cancer     modulating arachidonic acid[J]. Transl Oncol,2025,52:
                   statistics 2022:GLOBOCAN estimates of incidence and
                                                                     102256
                   mortality worldwide for 36 cancers in 185 countries[J].
                                                                [13]MA X H,LIU J H,LIU C Y,et al. ALOX15⁃launched PU⁃
                   CA Cancer J Clin,2024,74(3):229-263
                                                                     FA⁃phospholipids peroxidation increases the susceptibility
             [2] 王嘉慧,李璐琪,张         悦,等. 膜联蛋白 ANXA5 调节黑
                                                                     of ferroptosis in ischemia⁃induced myocardial damage[J].
                   色素瘤细胞铁死亡及其机制研究[J]. 南京医科大学学
                                                                     Signal Transduct Target Ther,2022,7(1):288
                   报(自然科学版),2025,45(2):157-164                  [14]ZHANG Y,SWANDA R V,NIE L,et al. mTORC1 cou⁃
                   WANG J H,LI L Q,ZHANG Y,et al. Mechanisms of an⁃  ples cyst(e)ine availability with GPX4 protein synthesis
                   nexin A5 regulating ferroptosis sensitivity in melanoma  and ferroptosis regulation[J]. Nat Commun,2021,12(1):
                   cells[J]. Journal of Nanjing Medical University(Natural  1589
                   Sciences),2025,45(2):157-164                 [15]CHEN Y,LEE D,KWAN K K,et al. Mevalonate pathway
             [3] MIYAZAKI K,XU C,SHIMADA M,et al. Curcumin and       promotes liver cancer by suppressing ferroptosis through
                   andrographis exhibit anti⁃tumor effects in colorectal can⁃  CoQ10 production and selenocysteine ⁃ tRNA modifica⁃
                   cer via activation of ferroptosis and dual suppression of  tion[J]. J Hepatol,2025,83(6):1338-1352
                   glutathione peroxidase⁃ 4 and ferroptosis suppressor pro⁃  [16]LV Y,LIANG C,SUN Q,et al. Structural insights into
                   tein⁃1[J]. Pharmaceuticals(Basel),2023,16(3):383  FSP1 catalysis and ferroptosis inhibition[J]. Nat Com⁃
             [4] WANG W,LU K,JIANG X,et al. Ferroptosis inducers en⁃  mun,2023,14(1):5933
                   hanced cuproptosis induced by copper ionophores in pri⁃  [17]MAO C,LIU X,ZHANG Y,et al. DHODH⁃mediated fer⁃
                   mary liver cancer[J]. J Exp Clin Cancer Res,2023,42  roptosis defence is a targetable vulnerability in cancer[J].
                  (1):142                                            Nature,2021,593(7860):586-590
             [5] GAMMELLA E,LOMORIELLO I S,CONTE A,et al. Un⁃   [18]KRAFT V A N,BEZJIAN C T,PFEIFFER S,et al. GTP
                   conventional endocytosis and trafficking of transferrin re⁃  cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis
                   ceptor induced by iron[J]. Mol Biol Cell,2021,32(2):  through lipid remodeling[J]. ACS Cent Sci,2020,6(1):

                   98-108                                            41-53
             [6] BARRA J,CROSBOURNE I,ROBERGE C L,et al. DMT1⁃  [19]FEARON E R,VOGELSTEIN B. A genetic model for
                   dependent endosome ⁃ mitochondria interactions regulate  colorectal tumorigenesis[J]. Cell,1990,61(5):759-767
                   mitochondrial iron translocation and metastatic out⁃  [20]BRUNET GUASCH M,FEELEY N A,SORIANO I,et al.
                   growth[J]. Oncogene,2024,43(9):650-667            Mathematical modeling quantifies "Just⁃Right" APC inac⁃
             [7] PATEL S J,PROTCHENKO O,SHAKOURY⁃ELIZEH M,           tivation for colorectal cancer initiation[J]. Cancer Res,
                   et al. The iron chaperone and nucleic acid⁃binding activi⁃  2025,85(24):5113-5127
                   ties of poly(rC)⁃binding protein 1 are separable and inde⁃  [21]WANG Y,ZHENG L,SHANG W,et al. Wnt/beta⁃catenin
                   pendently essential[J]. Proc Natl Acad Sci U S A,2021,  signaling confers ferroptosis resistance by targeting GPX4
                   118(25)                                           in gastric cancer[J]. Cell Death Differ,2022,29(11):
             [8] WILBON A S,SHEN J,RUCHALA P,et al. Structural       2190-2202
                   basis of ferroportin inhibition by minihepcidin PR73[J].  [22]FENG J,HU Z,XIA X,et al. Feedback activation of EG⁃
                   PLoS Biol,2023,21(1):e3001936                     FR/wild⁃type RAS signaling axis limits KRAS(G12D)in⁃
             [9] HOELZGEN F,NGUYEN T T P,KLUKIN E,et al. Struc⁃      hibitor efficacy in KRAS(G12D)⁃mutated colorectal can⁃
   61   62   63   64   65   66   67   68   69   70   71